Ian F. Smith, EVP & CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 202 shares at $82.06 ($17K) on 2016-05-16, disclosed to the SEC on 2016-05-18.
Scheduled sale ($17k) by EVP & CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ACOR | SELL | 2018-06-19 | $786K | — | Filing → |
| VRTX | SELL | 2018-05-16 | $34K | — | Filing → |
| VRTX | SELL | 2018-05-15 | $635K | — | Filing → |